{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:04:52Z","timestamp":1784196292312,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Phys Eng Sci Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13246-026-01701-x","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:05:52Z","timestamp":1778072752000},"page":"759-769","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monte Carlo-based dosimetric comparison of CCA and CCB radioactive eye plaques for uveal melanoma"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-8694","authenticated-orcid":false,"given":"Parvin","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Gili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"10","key":"1701_CR1","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1002\/mp.17257","volume":"51","author":"S Mishra","year":"2024","unstructured":"Mishra S, Selvam TP, Sahoo S, Saxena SK, Kumar Y, Sapra BK (2024) Monte Carlo-based dosimetry of proposed bi-radionuclide 125I and \u00b9\u2070\u2076Ru\/\u00b9\u2070\u2076Rh eye plaque: a feasibility study. Med Phys 51(10):7561\u20137573","journal-title":"Med Phys"},{"issue":"19","key":"1701_CR2","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.3390\/cancers16193386","volume":"16","author":"GN Thomas","year":"2024","unstructured":"Thomas GN, Chou I-L, Gopal L (2024) Plaque radiotherapy for ocular melanoma. Cancers 16(19):3386","journal-title":"Cancers"},{"issue":"1","key":"1701_CR3","first-page":"47","volume":"12","author":"Z Fardi","year":"2023","unstructured":"Fardi Z, Taherparvar P (2023) Dosimetric comparison of two models of \u00b9\u2070\u2076Ru\/\u00b9\u2070\u2076Rh eye plaque in brachytherapy treatment of eye melanoma using GATE Monte Carlo code. J Radiation Saf Meas 12(1):47\u201355","journal-title":"J Radiation Saf Meas"},{"key":"1701_CR4","doi-asserted-by":"crossref","unstructured":"Kritfuangfoo T, Tipsuriyaporn B, Thongborisuth T, Piriyasang D, Dangprasert S, Narkwong L et al (eds) (2025) \u00b9\u2070\u2076Ru plaque brachytherapy for the management of intraocular tumors in thailand: the first report from Southeast Asia. Seminars in ophthalmology. Taylor & Francis","DOI":"10.1080\/08820538.2024.2448522"},{"issue":"4","key":"1701_CR5","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.ijrobp.2006.02.002","volume":"65","author":"AO Schueler","year":"2006","unstructured":"Schueler AO, Fl\u00fchs D, Anastassiou G, Jurklies C, Neuh\u00e4user M, Schilling H et al (2006) \u03b2-Ray brachytherapy with \u00b9\u2070\u2076Ru plaques for retinoblastoma. Int J Radiat Oncol Biol Phys 65(4):1212\u20131221","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"1701_CR6","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E et al (2007) Incidence of uveal melanoma in Europe. Ophthalmol 114(12):2309\u201315e2","journal-title":"Ophthalmology"},{"issue":"12","key":"1701_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","volume":"109","author":"LM Jampol","year":"2002","unstructured":"Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP et al (2002) The COMS randomized trial of 125I brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report 19. Ophthalmology 109(12):2197\u20132206","journal-title":"Ophthalmology"},{"key":"1701_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejmp.2018.04.105","volume":"56","author":"F Rossi","year":"2018","unstructured":"Rossi F, Belli G, Fedeli L, Gori C, Genovese E, Cannat\u00e0 V et al (2018) 95. Pre and post-operative radiation protection in \u00b9\u2070\u2076Ru opthalmic brachytherapy. Physica Med 56:120\u2013121","journal-title":"Physica Med"},{"issue":"2","key":"1701_CR9","doi-asserted-by":"publisher","first-page":"S749","DOI":"10.1016\/j.ijrobp.2013.06.1985","volume":"87","author":"M Ferreira","year":"2013","unstructured":"Ferreira M, Jung J (2013) Dosimetry of 188Re, \u00b9\u2074\u00b2Pr, and 90Y Using Monte Carlo simulation for application in high-dose-rate eye plaque brachytherapy. Int J Radiat Oncol Biol Phys 87(2):S749\u2013S50","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1701_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12964-024-01883-5","volume":"22","author":"GL Bellot","year":"2024","unstructured":"Bellot GL, Liu D, Fivaz M, Yadav SK, Kaur C, Pervaiz S (2024) Lanthanide conjugate Pr-MPO elicits anti-cancer activity by targeting lysosomal machinery and inducing zinc-dependent cataplerosis. Cell Communication Signal 22(1):509","journal-title":"Cell Communication Signal"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.apradiso.2017.09.028","volume":"130","author":"G Famulari","year":"2017","unstructured":"Famulari G, Urlich T, Armstrong A, Enger SA (2017) Practical aspects of 153Gd as a radioactive source for use in brachytherapy. Appl Radiat Isot 130:131\u2013139","journal-title":"Appl Radiat Isot"},{"key":"1701_CR12","volume-title":"Brachytherapy","author":"I Orion","year":"2012","unstructured":"Orion I, Rubin E (2012) Dose calculations of the \u00b9\u2070\u2076Ru \/\u00b9\u2070\u2076Rh CCA and CCB eyes applicators. In: Kishi K (ed) Brachytherapy. IntechOpen, Rijeka"},{"issue":"4","key":"1701_CR13","first-page":"309","volume":"13","author":"M Arjmand","year":"2023","unstructured":"Arjmand M, Ghassemi F, Rafiepour P, Zeinali R, Riazi-Esfahani H, Beiki-Ardakani A (2023) Dosimetric investigation of six \u00b9\u2070\u2076Ru eye plaques by EBT3 radiochromic films and Monte Carlo simulation. J Biomed Phys Eng 13(4):309\u2013316","journal-title":"J Biomed Phys Eng"},{"key":"1701_CR14","doi-asserted-by":"crossref","unstructured":"Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P et al (2003) Geant4\u2014a simulation toolkit. Nuclear instruments and methods in physics research section A: accelerators, spectrometers, detectors and associated equipment. 506(3):250\u2013303","DOI":"10.1016\/S0168-9002(03)01368-8"},{"key":"1701_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nima.2016.06.125","volume":"835","author":"J Allison","year":"2016","unstructured":"Allison J, Amako K, Apostolakis J, Arce P, Asai M, Aso T et al (2016) Recent developments in Geant4. Nuclear instruments and methods in physics research section A: accelerators, spectrometers. Detectors Assoc Equip 835:186\u2013225","journal-title":"Detectors Assoc Equip"},{"issue":"1","key":"1701_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1109\/TNS.2006.869826","volume":"53","author":"J Allison","year":"2006","unstructured":"Allison J, Amako K, Apostolakis J, Araujo H, Dubois PA, Asai M et al (2006) Geant4 developments and applications. IEEE Trans Nucl Sci 53(1):270\u2013278","journal-title":"IEEE Trans Nucl Sci"},{"issue":"3","key":"1701_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.icrp.2008.10.001","volume":"38","author":"K Eckerman","year":"2008","unstructured":"Eckerman K, Endo A (2008) ICRP publication 107. Nuclear decay data for dosimetric calculations. Ann ICRP 38(3):7\u201396","journal-title":"Ann ICRP"},{"key":"1701_CR18","unstructured":"L\u2019Annunziata MF (2012) Handbook of radioactivity analysis. Academic"},{"key":"1701_CR19","doi-asserted-by":"publisher","first-page":"111636","DOI":"10.1016\/j.apradiso.2024.111636","volume":"217","author":"Z Fardi","year":"2025","unstructured":"Fardi Z, Taherparvar P (2025) Monte Carlo investigation of dose distribution of two model \u00b9\u2070\u2076Ru\/\u00b9\u2070\u2076Rh ophthalmic plaques in a realistic human eye model with different uveal melanoma size. Appl Radiat Isot 217:111636","journal-title":"Appl Radiat Isot"}],"container-title":["Physical and Engineering Sciences in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13246-026-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13246-026-01701-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13246-026-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:14:55Z","timestamp":1784193295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13246-026-01701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s13246-026-01701-x","relation":{},"ISSN":["2662-4729","2662-4737"],"issn-type":[{"value":"2662-4729","type":"print"},{"value":"2662-4737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research involved purely theoretical and simulation-based methods. No human or animal subjects were recruited, and no biological or clinical samples were used. Consequently, ethics approval was not applicable for this study. The authors confirm that all relevant ethical standards were considered during the design and execution of the simulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}